• LAST PRICE
    1.5800
  • TODAY'S CHANGE (%)
    Trending Up0.0200 (1.2821%)
  • Bid / Lots
    1.5800/ 122
  • Ask / Lots
    1.5900/ 4
  • Open / Previous Close
    1.5500 / 1.5600
  • Day Range
    Low 1.5400
    High 1.6099
  • 52 Week Range
    Low 1.1500
    High 4.7000
  • Volume
    101,839
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.56
TimeVolumeCDXC
09:32 ET16491.54
09:33 ET4001.57
09:35 ET41891.58
09:37 ET49171.575
09:39 ET289601.54
09:42 ET8021.55
09:44 ET13481.55
09:46 ET7501.55
09:48 ET2501.5599
09:50 ET7501.555
09:51 ET3501.54
09:53 ET1001.55
09:55 ET16001.54
09:57 ET5001.56
10:00 ET6501.57
10:02 ET7001.58
10:04 ET6001.585
10:06 ET14501.56
10:08 ET4501.58
10:09 ET11501.6
10:11 ET5001.605
10:13 ET4501.605
10:15 ET7501.605
10:18 ET7501.605
10:20 ET2501.6099
10:26 ET1001.605
10:29 ET5001.605
10:31 ET4001.6
10:38 ET13001.595
10:54 ET5001.59
11:00 ET21001.58
11:03 ET3001.5891
11:05 ET36001.58
11:07 ET17001.5889
11:12 ET4001.585
11:18 ET3001.585
11:45 ET28001.58
12:01 ET1001.58
12:08 ET14841.57
12:10 ET2001.58
12:17 ET1001.58
12:19 ET3491.585
12:21 ET7001.5801
12:24 ET1001.575
12:30 ET4001.575
12:32 ET1001.575
12:33 ET1001.575
12:35 ET2021.57
12:37 ET1271.58
12:39 ET2001.575
12:48 ET3001.575
12:55 ET139421.58
12:57 ET5001.585
01:00 ET7001.59
01:06 ET6001.585
01:08 ET1201.5887
01:09 ET1001.585
01:13 ET12001.58
01:15 ET1001.585
01:18 ET1001.5815
01:24 ET2501.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCDXC
Chromadex Corp
116.2M
-5.3x
---
United StatesCLLS
Cellectis SA
101.6M
-1.0x
---
United StatesCTMX
CytomX Therapeutics Inc
107.1M
-1.0x
---
United StatesFBIO
Fortress Biotech Inc
78.2M
-0.6x
---
United StatesMREO
Mereo Biopharma Group PLC
99.4M
-0.1x
---
United StatesBIOQ
Bioqual Inc
63.5M
12.1x
+5.80%
As of 2022-12-09

Company Information

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Contact Information

Headquarters
10900 Wilshire Blvd, Suite 600LOS ANGELES, CA, United States 90024
Phone
310-388-6706
Fax
302-421-5753

Executives

Chief Executive Officer, Director
Robert Fried
Interim Chief Financial Officer, Senior Vice President - Finance
Brianna Gerber
Independent Director
Ann Cohen
Independent Director
Gary Ng
Independent Director
Kristin Patrick

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$116.2M
Revenue (TTM)
$68.8M
Shares Outstanding
74.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.70
EPS
$-0.30
Book Value
$0.47
P/E Ratio
-5.3x
Price/Sales (TTM)
1.7
Price/Cash Flow (TTM)
---
Operating Margin
-32.70%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.